Details checkedClinical trial listing onlyCheckedregistry

Assiut Hyaluronic Acid plus Dexamethasone SSNHL Study

Also known as: Hyaluronic Acid (HA), Hyaluronic acid with dexamethasone injection, Intratympanic Injection of Dexamethasone With Hyaluronic Acid, NCT06878599

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Drug Delivery

Stage

Phase 4

Status

Active

Target Gene

—

Route / Mode

Intratympanic injection

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Egypt

Population

adult, sudden, sensorineural

Trial IDs

Mechanism

Not-yet-recruiting Phase 4 academic trial evaluating intratympanic hyaluronic acid added to dexamethasone versus dexamethasone alone for sudden sensorineural hearing loss.

Indications

Hearing Loss Sensorineural Hearing Loss Sudden Sensorineural Hearing Loss

Notes

Verified as a focused Assiut study now split out from the broad dexamethasone cluster. Dexamethasone alone is the active comparator; this should be treated as a study-level intratympanic drug-delivery adjunct record.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT06878599

Open

Key Events

2025-05-01

Registry lists estimated start for hyaluronic acid plus dexamethasone SSNHL study

Clinical Trials (1)

NCT06878599

Data Checks